Given the user's beginner investment level, long-term strategy, and available capital, ARQ is not a strong buy at this time. The stock is facing significant challenges including poor financial performance, negative sentiment, and lack of clear growth catalysts. It is better to wait for more stability and clearer signals before investing.
The technical indicators suggest a bearish trend. The MACD is below 0 and negatively contracting, the RSI is neutral at 37.6, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). Key support and resistance levels indicate potential volatility, with the stock trading near support levels (S1: 1.657).

The stock showed a regular market price increase of 8.95% and a post-market gain of 1.21%, indicating some short-term recovery. Analysts maintain a Buy rating despite reduced price targets, suggesting potential long-term value.
The company missed Q4 earnings expectations significantly, reported a revenue guidance cut for 2026, and paused a key production project. Additionally, there is an ongoing securities fraud investigation, and the stock has faced a sharp decline in recent days.
In Q4 2025, revenue increased by 8.84% YoY to $29.43 million, but net income worsened significantly to -$50.03 million, up 3636.15% YoY in losses. EPS also declined to -1.2, and gross margin dropped by 91.59% YoY to 2.27%.
Analysts have lowered price targets (Canaccord: $5 from $7.50; Clear Street: $6.50 from $8) due to execution challenges and project delays. However, both maintain a Buy rating, citing attractive risk/reward for long-term investors.